Pharmacy Joe

JUNE 7, 2023

Subscribe on iTunes , Android , or Stitcher Whether torsemide improves patient Heart Failure (HF) symptoms and quality of life better than furosemide is a matter of debate among clinicians, and a group of authors recently published an open-label, multi-center, randomized trial in the journal Circulation in an effort to resolve this question.

Hospitals 59

Hospitals Inpatient Labelling 59

Pharmacy Joe

DECEMBER 7, 2022

This was an open label randomized trial of 110 patients who were evenly split between IV and nebulized tranexamic acid groups. To get access to my free download area with 20 different resources to help hospital pharmacists go to pharmacyjoe.com/free.

Inpatient 52

Inpatient Labelling Hospitals 52

Pharmacy Joe

JUNE 17, 2023

Authors recently published in New England Journal of Medicine an open label multi center trial looking at early vs later anticoagulation in patients with afib who had an ischemic stroke. To access my free download area with 20 different resources to help you in your practice, go to pharmacyjoe.com/free.

Inpatient 52

Inpatient Labelling 52

Pharmacy Joe

SEPTEMBER 3, 2023

To access my free download area with 20 different resources to help you in your practice, go to pharmacyjoe.com/free. If you like this post, check out my book – A Pharmacist’s Guide to Inpatient Medical Emergencies: How to respond to code blue, rapid response calls, and other medical emergencies. <–

Labelling 52

Labelling Hospitals Inpatient 52

Pharmacy Joe

SEPTEMBER 3, 2023

To access my free download area with 20 different resources to help you in your practice, go to pharmacyjoe.com/free. If you like this post, check out my book – A Pharmacist’s Guide to Inpatient Medical Emergencies: How to respond to code blue, rapid response calls, and other medical emergencies. <–

Labelling 52

Labelling Hospitals Inpatient 52

Pharmacy Joe

DECEMBER 6, 2023

This was a multi-center trial that randomized over 800 hemodynamically unstable potential heart donors within 24 hours after declaration of death according to neurologic criteria to either an open-label infusion of intravenous levothyroxine at 30 mcg/hr or saline placebo.

Inpatient 52

Inpatient Labelling 52

Pharmacy Joe

DECEMBER 6, 2023

This was a multi-center trial that randomized over 800 hemodynamically unstable potential heart donors within 24 hours after declaration of death according to neurologic criteria to either an open-label infusion of intravenous levothyroxine at 30 mcg/hr or saline placebo.

Inpatient 52

Inpatient Labelling 52

Pharmacy Joe

OCTOBER 22, 2023

The ACORN randomized trial sought to compare rates of AKI and neurotoxicity in patients hospitalized with acute infection who were randomized 1:1 in an open-label fashion to receive either piperacillin-tazobactam or cefepime for gram-negative coverage. However, other studies have examined a link between increased neurotoxicity with cefepime.

Hospitals 52

Hospitals Labelling Inpatient 52

Pharmacy Joe

OCTOBER 22, 2023

The ACORN randomized trial sought to compare rates of AKI and neurotoxicity in patients hospitalized with acute infection who were randomized 1:1 in an open-label fashion to receive either piperacillin-tazobactam or cefepime for gram-negative coverage. However, other studies have examined a link between increased neurotoxicity with cefepime.

Hospitals 52

Hospitals Labelling Inpatient 52

Pharmacy Joe

MARCH 7, 2024

Back in episode 473 , I talked about the evidence behind the discrepancy between the labeled dose and the analgesic ceiling dose of IV ketorolac. ” To access my free download area with 20 different resources to help you in your practice, go to pharmacyjoe.com/free. There is similar data on the ceiling dose of ibuprofen as well.

Inpatient 52

Inpatient Dosage Labelling 52

Pharmacy Joe

AUGUST 5, 2020

If using this off-label strategy, give preference to the preservative-free version of IV tranexamic acid due to the potential adverse effects of nebulized preservatives. To access my free download area with 20 different resources to help you in your practice, go to pharmacyjoe.com/free. 009 in the tranexamic acid group).

Inpatient 40

Inpatient Labelling Hospitals 40

Pharmacy Joe

NOVEMBER 29, 2020

To improve the data available in this patient population, investigators in Brazil completed a multicenter, randomized, open-label, noninferiority trial with 1000 patients comparing rivaroxaban with warfarin for patients with atrial fibrillation and a bioprosthetic mitral valve.

Inpatient 40

Inpatient Labelling Hospitals 40

Pharmacy Joe

NOVEMBER 10, 2021

The RECOVERY Trial, which is a randomized, controlled, open-label trial, underway at 177 hospitals recently published results of using colchicine in patients admitted to hospital with COVID-19. To access my free download area with 20 different resources to help you in your practice, go to pharmacyjoe.com/free.

Hospitals 40

Hospitals Inpatient Dosage Labelling 40

Pharmacy Joe

AUGUST 21, 2022

Recently published in Lancet was a non-inferiority, open-label, multicentre, randomized trial that sought to clarify the safety of early antibiotic discontinuation in hematology patients with fever of unknown origin during chemotherapy-induced neutropenia.

Chemotherapy 52

Chemotherapy Inpatient Labelling 52

Pharmacy Joe

DECEMBER 7, 2022

This was an open label randomized trial of 110 patients who were evenly split between IV and nebulized tranexamic acid groups. To get access to my free download area with 20 different resources to help hospital pharmacists go to pharmacyjoe.com/free.

Inpatient 40

Inpatient Labelling Hospitals 40

Pharmacy Joe

NOVEMBER 25, 2020

To access my free download area with 20 different resources to help you in your practice, go to pharmacyjoe.com/free. If you like this post, check out my book – A Pharmacist’s Guide to Inpatient Medical Emergencies: How to respond to code blue, rapid response calls, and other medical emergencies. <–

Labelling 40

Labelling Hospitals Inpatient 40

Pharmacy Joe

NOVEMBER 12, 2023

Secondary outcome measures were numerically favorable for haloperidol including the need for open-label haloperidol or other antipsychotics, and self-extubation or invasive device removal. To access my free download area with 20 different resources to help you in your practice, go to pharmacyjoe.com/free.

Hospitals 52

Hospitals Inpatient Labelling 52

Pharmacy Joe

NOVEMBER 12, 2023

Secondary outcome measures were numerically favorable for haloperidol including the need for open-label haloperidol or other antipsychotics, and self-extubation or invasive device removal. To access my free download area with 20 different resources to help you in your practice, go to pharmacyjoe.com/free.

Hospitals 52

Hospitals Inpatient Labelling 52

Pharmacy Joe

SEPTEMBER 20, 2021

Back in episode 473 , I talked about the evidence behind the discrepancy between the labeled dose and the analgesic ceiling dose of IV ketorolac. ” To access my free download area with 20 different resources to help you in your practice, go to pharmacyjoe.com/free. There is similar data on the ceiling dose of ibuprofen as well.

Inpatient 40

Inpatient Dosage Labelling 40

Pharmacy Joe

OCTOBER 3, 2021

A group of authors recently published in NEJM the results of a randomized, multicenter, open-label, parallel-group trial in the UK examining this issue. To access my free download area with 20 different resources to help you in your practice, go to pharmacyjoe.com/free. The most common cause for cirrhosis was alcohol.

Hospitals 40

Hospitals Inpatient Labelling 40

Pharmacy Joe

MAY 25, 2022

A group of authors from Sorbonne University in Paris, France conducted a randomized open label multicenter trial to examine whether an 8 day course of therapy for Pseudomonas VAP (PA-VAP) could be non-inferior to a 15 day course. 25 of 98 patients in the 15-day group and 31 of 88 patients in the 8-day group reached the composite endpoint.

Inpatient 40

Inpatient Labelling Hospitals 40

Pharmacy Joe

APRIL 20, 2022

This was a multicenter, open-label, noninferiority randomized clinical trial of 206 ICU patients with VAP. To access my free download area with 20 different resources to help you in your practice, go to pharmacyjoe.com/free.

Inpatient 40

Inpatient Labelling 40

Pharmacy Joe

DECEMBER 22, 2021

The study was a prospective, randomized, open-label, parallel assignment, single-center clinical trial of 801 patients. To access my free download area with 20 different resources to help you in your practice, go to pharmacyjoe.com/free. A recent article published in the journal Intensive Care Medicine examined this issue.

Inpatient 40

Inpatient Labelling 40

Pharmacy Joe

AUGUST 21, 2022

Recently published in Lancet was a non-inferiority, open-label, multicentre, randomized trial that sought to clarify the safety of early antibiotic discontinuation in hematology patients with fever of unknown origin during chemotherapy-induced neutropenia.

Chemotherapy 40

Chemotherapy Inpatient Labelling 40

Pharmacy Joe

DECEMBER 27, 2020

The study was a single-center, randomized, open-label pilot study. To access my free download area with 20 different resources to help you in your practice, go to pharmacyjoe.com/free. One for Sodium Zirconium Cyclosilicate and one for Patiromer. The patiromer study was published in Academic Emergency Medicine January 2020.

Inpatient 40

Inpatient Labelling 40

RX Note

FEBRUARY 23, 2023

Terazosin - Off-label use in ureteral stone(s) expulsion Topical Corticosteroids - Apply thinly on the skin using fingertip unit. Statins - Not all statins need to be taken at night.

HIV Treatment and Prevention Agents 58

HIV Treatment and Prevention Agents Community Pharmacies Labelling Chemotherapy 58

Pharmacy Joe

DECEMBER 22, 2024

This was an open label randomized trial of 110 patients who were evenly split between IV and nebulized tranexamic acid groups. To get access to my free download area with 20 different resources to help hospital pharmacists go to pharmacyjoe.com/free.

Inpatient 105

Inpatient Labelling Hospitals 105

Pharmacy Joe

NOVEMBER 24, 2024

Milrinone labeling suggests a renal dose adjustment for patients with creatinine clearance between 10 and 50 mL/min but has no recommendations or data available for patients with ESRD or who are receiving CRRT. To access my free download area with 20 different resources to help you in your practice, go to pharmacyjoe.com/free.

Inpatient 52

Inpatient Labelling 52